Akari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps Down

RTTNews | 21 days ago
Akari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps Down

(RTTNews) - Biotechnology company Akari Therapeutics, Plc (AKTX) announced Wednesday leadership changes, including the appointment of experienced life sciences entrepreneur Samir Patel as interim Chief Executive Officer.

Rachelle Jacques will step down as Akari's CEO effective today. Melissa Bradford-Klug will step down as Akari's Chief Operating Officer effective today. In connection with Jacques' departure, Akari's board of directors has appointed Patel as Interim CEO. Patel has served as a member of the Board since December 2023.

Patel is a long-time supporter and investor in Akari and brings in broad life sciences experience and a track record of multiple successful startup companies.

Patel currently serves as founder and principal of PranaBio Investments, LLC. He is also a consultant to GE Global Research, GE's innovation engine that is creating novel products and solutions across several sectors including biomanufacturing and biotechnology.

He has more than 20 years of experience in life sciences including co-founding Digital Therapeutics, LLC, and SPEC Pharma, LLC. Previously, Patel held multiple roles in Medical Affairs with Centocor, Inc.

read more
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Canadian shares are likely to open on a slightly negative note Wednesday morning as energy and materials sectors may find the going somewhat tough due to weak commodity prices.
RTTNews | 4h 24min ago
Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone payments.
RTTNews | 4h 27min ago
UK Inflation Slows Less Than Expected To 2.3%

UK Inflation Slows Less Than Expected To 2.3%

UK consumer prices rose more than expected in April due to the stickiness of services inflation, which would possibly delay the timing of the first interest rate cut. Consumer prices rose 2.3 percent on a yearly basis in April, slower than the 3.2 percent increase in March, the Office for National Statistics reported Wednesday.
RTTNews | 4h 37min ago
Target Q1 Profit Misses Estimates, Backs FY24 View; Stock Down

Target Q1 Profit Misses Estimates, Backs FY24 View; Stock Down

Target Corp. shares were losing more than 8 percent in pre-market activity on the NYSE after the general merchandise retailer reported weak profit, sales and comparable sales in its first quarter. Earnings per share missed the Street estimates. Further, the company issued second-quarter outlook and maintained fiscal 2024 forecast.
RTTNews | 5h 29min ago
RBNZ Holds Key Interest Rate; Delays Rate Cut Plan

RBNZ Holds Key Interest Rate; Delays Rate Cut Plan

New Zealand's central bank maintained its benchmark rate for the seventh consecutive session and signaled a delay in rate cuts as services inflation is receding slowly. The Monetary Policy Committee of the Reserve Bank of New Zealand, led by Governor Adrian Orr, decided to hold the Official Cash Rate at 5.50 percent.
RTTNews | 5h 53min ago